Charles River Laboratories International (CRL) Assets (2009 - 2025)

Charles River Laboratories International (CRL) has reported Assets for 17 consecutive years, with $7.1 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Assets fell 5.22% year-over-year to $7.1 billion; the TTM figure through Dec 2025 stood at $7.1 billion (down 5.22% YoY), while the FY2025 annual figure was $7.1 billion, down 5.22% from the prior year.
• Assets came in at $7.1 billion for Q4 2025 at Charles River Laboratories International, down from $7.5 billion in the prior quarter.
• The five-year high for Assets was $8.2 billion in Q4 2023, with the low at $5.8 billion in Q1 2021.
• Average Assets over 5 years is $7.4 billion, with a median of $7.5 billion recorded in 2022.
• Across the five-year window, Assets grew 28.23% in 2021 and fell 8.13% in 2024, its largest moves.
• Year by year, Assets stood at $7.0 billion in 2021, then grew by 8.24% to $7.6 billion in 2022, then advanced by 7.79% to $8.2 billion in 2023, then declined by 8.13% to $7.5 billion in 2024, then fell by 5.22% to $7.1 billion in 2025.
• According to Business Quant data, Assets over the past three periods registered $7.1 billion, $7.5 billion, and $7.6 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.